Editis stock
WebMay 11, 2024 · Demain, et grâce à l’impressionnant arraisonnement accompli au sein du groupe Lagardère, il s’étendra à Europe 1, au Journal du dimanche, à Paris-Match, et au groupe Hachette (Grasset, Stock, Le Livre de proche, Calmann-Lévy, JC Lattès, Larousse, Hatier, Fayard, etc.). – tout en se délestant alors d’Editis (décision annoncée ... WebApr 6, 2024 · Editas Medicine (EDIT 1.02%) and Bluebird Bio (BLUE 0.98%) are both beaten-down gene-editing stocks. Editas' shares are down by 65% in the last 12 …
Editis stock
Did you know?
Web1 day ago · Editas Medicine’s lead therapy looks like it will be late out of the gate. ... Reason No. 1 to stay away: The stock already had one reverse stock split back in July. Now trading at around $1.53 ... WebEditas Medicine Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for EDIT All Analysts Top Analysts Based on 13 analyst s offering 12 month price targets for Editas Medicine Inc. Min Forecast $7.00 +1.16% Avg Forecast $16.62 +140.1% Max Forecast $36.00 +420.23%
Web6 hours ago · Editas Medicine (EDIT) shares soared 20.3% in the last trading session to close at $7.65. The move was backed by solid volume with far more shares changing … WebFeb 15, 2024 · Overview Editas Medicine Investors Stock Quote Change Volume 52 Week High 52 Week Low Apr 10, 2024 10:05 AM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed. Upcoming Events More events are coming soon. Recent News March 8, …
WebApr 12, 2024 · A high-level overview of Editas Medicine, Inc. (EDIT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebApr 13, 2024 · CAMBRIDGE, Mass., April 13, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced the appointment of current Independent Director Emma Reeve as Chair of the Board, effective at the Company’s next annual stockholder meeting, currently scheduled for …
WebApr 13, 2024 · Editas Medicine Inc. (NASDAQ:EDIT) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -5.22% to the previous day’s close as strong …
WebEDIT Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research EDITAS MEDICINE, INC. EDITAS MEDICINE, INC. 8.57 -4.35% … callaway overstockWeb2 days ago · Editas shares jump 9% on positive news from sickle-cell study Provided by Dow Jones Dec 6, 2024 1:00 PM UTC Editas Medicine Gets FDA Rare Pediatric … coats at macy\\u0027sWebEditas Medicine stock price target cut to $35 from $80 at Truist Nov. 18, 2024 at 7:08 a.m. ET by Tomi Kilgore Editas Medicine started at neutral with $18 stock price target at BofA... callaway pacifica women\u0027s golf shoeWebAug 11, 2024 · The stock price of Editas Medicine, a biotechnology company focused on developing treatments using gene editing technology, has seen a rise of over 20% over the last twenty-one trading days, and ... coats at primark for womenWebApr 13, 2024 · The stock has traded between $6.36 and $7.64 so far today. Volume today is elevated. So far 2,503,752 shares have traded compared to average volume of … callaway pantsWebApr 11, 2024 · According to analysts, Editas Medicine's stock has a predicted upside of 46.92% based on their 12-month price targets. What analysts cover Editas Medicine? Editas Medicine has been rated by Cantor Fitzgerald, Chardan Capital, Credit Suisse Group, Morgan Stanley, Royal Bank of Canada, SVB Leerink, and Wells Fargo & … callaway oversize golf ballsWebAt Editas Medicine, we are pioneering the possible. Our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world. coats ats